SCHEDULE 13G/A: Adage Capital Management Discloses 3% Stake in enGene Holdings Inc. via Amended 13G Filing
Beneficial Ownership Report
Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has filed an amended Schedule 13G disclosing a 3.00% beneficial ownership stake in enGene Holdings Inc., totaling 1,528,768 common shares as of December 31, 2024.
Summary
- Adage Capital Management, L.P., a Delaware limited partnership, along with its managing members Robert Atchinson and Phillip Gross, reported beneficial ownership of 1,528,768 common shares of enGene Holdings Inc.
- This ownership represents 3.00% of enGene Holdings Inc.'s total outstanding common shares.
- The percentage is calculated based on 50,976,676 common shares outstanding as of December 16, 2024, as reported in enGene Holdings Inc.'s Annual Report on Form 10-K filed on December 19, 2024.
- The reporting persons hold both shared voting power and shared dispositive power over the 1,528,768 shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership position.
- The reporting persons certify that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of enGene Holdings Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently be considered positive or negative for the company's performance or outlook. It is a routine regulatory filing.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive dynamics for enGene Holdings Inc. It indicates a significant, but non-controlling, investment by Adage Capital Management, a prominent investment firm.
Stakeholder Impact
- The filing indicates a notable, but passive, investment by Adage Capital Management, which may be viewed positively by other investors as a vote of confidence from a sophisticated institutional fund.
- Given the non-controlling nature and the explicit statement of not seeking to influence control, the direct impact on other stakeholders like employees, customers, or suppliers is minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-10-31 | End of fiscal year for enGene Holdings Inc.'s Annual Report on Form 10-K, which provided the basis for outstanding shares. |
| 2024-12-16 | Date as of which 50,976,676 common shares of enGene Holdings Inc. were reported outstanding. |
| 2024-12-19 | Date enGene Holdings Inc. filed its Annual Report on Form 10-K with the Securities and Exchange Commission. |
| 2024-12-31 | Date of the event which required the filing of this statement (the beneficial ownership position date). |
| 2025-02-12 | Date of signing and filing of the Schedule 13G Amendment No. 1. |
Keywords
enGene Holdings Inc., Adage Capital Management, Schedule 13G, Beneficial Ownership, Common Shares, Institutional Investor, SEC Filing, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.